Prosecution Insights
Last updated: April 19, 2026

Remenick Pllc

8 pending office actions • 6 clients

Portfolio Summary

8
Total Pending OAs
5
Final Rejections
3
Non-Final OAs

Client Portfolio (6 clients)

Client (Assignee)Pending OAs
Longhorn Vaccines And Diagnostics, LLC 2
Respiratory Motion, Inc. 2
Zynex Monitoring Solutions, Inc. 1
Fina Biosolutions, LLC 1
BHARAT BIOTECH INTERNATIONAL LIMITED 1
Inventprise, LLC 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18366915 VACCINES FOR THE TREATMENT AND PREVENTION OF SEASONAL AND EMERGING INFECTIONS Longhorn Vaccines And Diagnostics, LLC GRIZER, CASSANDRA SENN 1672 Non-Final OA Aug 08, 2023
18321195 Moisture Protected Photoplethysmographic Laser Housing Zynex Monitoring Solutions, Inc. FARDANESH, MARJAN 3791 Non-Final OA May 22, 2023
17985296 Immunogenic Compositions and Vaccines in the Treatment and Prevention of Infections Longhorn Vaccines And Diagnostics, LLC LUNDE, GRACE HENRY 1641 Non-Final OA Nov 11, 2022
17797851 Production of Soluble Recombinant Protein Fina Biosolutions, LLC HOLLAND, PAUL J 1656 Final Rejection Aug 05, 2022
17877986 Buffer Free, Acid Stable Low Dose Volume Rotavirus Vaccine BHARAT BIOTECH INTERNATIONAL LIMITED CHEN, STACY BROWN 1672 Final Rejection Jul 31, 2022
17486174 RESPIRATORY EARLY WARNING SCORING SYSTEMS AND METHODS Respiratory Motion, Inc. BLOCH, MICHAEL RYAN 3791 Final Rejection Sep 27, 2021
17151445 Multivalent Streptococcus Vaccines Inventprise, LLC DEVI, SARVAMANGALA 1645 Final Rejection Jan 18, 2021
15255413 DEVICES AND METHODS FOR NON-INVASIVE VENTILATION THERAPY Respiratory Motion, Inc. WOLFF, ARIELLE R 3785 Final Rejection Sep 02, 2016

Managing Remenick Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month